s41598-022-23676-x.pdf (914.91 kB)
Download file

Quality of life questionnaires validate a remote approach to ophthalmic management of primary Sjögren's syndrome

Download (914.91 kB)
journal contribution
posted on 17.11.2022, 17:40 authored by Emily Greenan, Qistina Pilson, Joan Ni Gabhann-DromgooleJoan Ni Gabhann-Dromgoole, Conor MurphyConor Murphy

Those with underlying autoimmune conditions were met with unparalleled challenges and were disproportionately affected by the COVID-19 pandemic. As such, we aimed to measure the impact of the pandemic on symptoms and the health and vision related quality of life (HR-QoL, VR-QoL) in patients with Primary Sjögren's Syndrome (pSS). Nineteen (55.9%) participants returned questionnaires for analysis, (17 female and 2 male, 61.6 years ± 9.9). There was no significant change in participants HR-QoL or VR-QoL, indicating that those with pSS remained resilient with regard to their physical and mental health throughout the pandemic. Furthermore, QoL was maintained despite 73.7% of participants having had outpatient appointments cancelled, delayed or rescheduled. Participants reported a lower QoL and feeling tenser in the COV19-QoL (3.3 ± 1.4 and 3.2 ± 1.3) representing feelings of apprehension and stress felt amongst the general population since the pandemic. Overall, and in spite of the concern caused by the COVID-19 pandemic for patients with autoimmune diseases, the health and well-being of patients with pSS remained stable. These findings strongly support the use of validated HR and VR-QoL questionnaires as an adjunct to the telemedicine consultation when assessing patients with pSS, offering an alternative to face-to-face consultations in post-pandemic era. 

Funding

The Royal Victoria Eye and Ear Hospital Research Foundation

Irish College of Ophthalmologists/Novartis Eye Research Bursary

History

Comments

The original article is available at https://www.nature.com/

Published Citation

Greenan E, Pilson Q, Ní Gabhann-Dromgoole J, Murphy CC. Quality of life questionnaires validate a remote approach to ophthalmic management of primary Sjögren's syndrome. Sci Rep. 2022;12(1):18761.

Publication Date

5 November 2022

PubMed ID

36335260

Department/Unit

  • Ophthalmology
  • School of Pharmacy and Biomolecular Sciences

Publisher

Springer Nature Limited

Version

  • Published Version (Version of Record)